Vaccine that harnesses antifungal immunity protects mice from staph
infection

Date:
August 20, 2020
Source:
PLOS
Summary:
Immunization of mice with a new vaccine consisting of fungal
particles loaded with Staphylococcus aureus (S. aureus) proteins
protects mice against S. aureus infection, according to a new study.



FULL STORY ========================================================================== Immunization of mice with a new vaccine consisting of fungal particles
loaded with Staphylococcus aureus (S. aureus) proteins protects mice
against S. aureus infection, according to a study published August 20
2020 in the open-access journal PLOS Pathogens by David Underhill of Cedars-Sinai Medical Center, and colleagues.


==========================================================================
S. aureus is one of the most common bacterial infections worldwide, and antibiotic-resistant strains such as methicillin-resistant S. aureus
(MRSA) are a major threat and burden to public health. MRSA not only
infects immunocompromised patients but also healthy individuals,
and has rapidly spread from the healthcare setting to the outside
community. Vaccines aimed at targeting S. aureus have failed in clinical trials, and the reason for this lack of success remains unclear. As this pathogen continues to rapidly spread on a global scale, it is vital that
new approaches to S. aureus vaccination are developed. Immunocompromised individuals such as patients with HIV are highly susceptible to S. aureus infections, and they are also at increased risk of developing fungal infections. Based on this evidence, Underhill and colleagues tested
whether stimulation of antifungal immunity would promote the type of
immune responses needed for effective host defense against S. aureus.

The researchers developed a new vaccine called 4X-SA-GP, which consists
of fungal ?-glucan particles loaded with four S. aureus proteins. Mice
were vaccinated once a week for three weeks with 4X-SA-GP, and then
injected with S.

aureus either four or eight weeks later. Vaccination induced protective
T cell and antibody responses, and the T cell responses in particular
were essential for vaccine-induced protection from S. aureus
infection. Moreover, the mice had detectable antibody levels and
reduced S. aureus levels in the spleen and kidneys eight weeks after immunization. According to the authors, this work potentially broadens
the use of the ?-glucan particle vaccine system for a much-needed vaccine targeting S. aureus.

The authors conclude, "We need some creative new approaches to explore
towards developing a S. aureus vaccine, and we are excited to share our
recent experiences with antigen-loaded fungal particles."

========================================================================== Story Source: Materials provided by PLOS. Note: Content may be edited
for style and length.


========================================================================== Journal Reference:
1. Marissa J. Paterson, JR Caldera, Christopher Nguyen, Purnima Sharma,
Anthony M. Castro, Stacey L. Kolar, Chih-Ming Tsai, Jose J. Limon,
Courtney A. Becker, Gisla^ine A. Martins, George Y. Liu, David M.

Underhill. Harnessing antifungal immunity in pursuit of a
Staphylococcus aureus vaccine strategy. PLOS Pathogens, 2020; 16
(8): e1008733 DOI: 10.1371/journal.ppat.1008733 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2020/08/200820143237.htm

--- up 5 weeks, 1 day, 1 hour, 55 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)